KDM7A and cancer: Our results indicate that KDM7A-DT upregulation in combination with KDM7A-DT-associated EMT Type II-III genes could be used to construct a KDM7A-DT-defined EMT Type III prognostic signature(s) of BLBC high-invasive and aggressive cancers.